Hypertonic saline 3%
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for Hypertonic saline 3%, covering 2012-12-07 to 2021-02-18. Get the full timeline:
Most recent: Clinical Trial Update: The Aim of This Study is to Compare the Efficacy of Perioperative Hypertonic Saline 3% Versus Normal Saline (0.9%) in Decreasing Recurrence Risk in Non-muscle Invasive Bladder Cancer [Phase 2]